Article Abstract

Subtype variation and actionability of telomere length abnormality in lung cancer

Authors: Felicia Goh, Ian A. Yang, Rayleen V. Bowman, Kwun M. Fong

Abstract

Lung cancer has a 5-year survival rate of only 18%. Among the many studies investigating factors associated with the high mortality rate of this cancer, Doherty et al. (1) recently examined telomere length in Cancer Epidemiology, Biomarkers & Prevention.